Progressive systemic sclerosis (PSS) is a chronic disease of unknown aetiology affecting connective tissue and small arteries. Its outcome is unpredictable because life-threatening systemic involvement may become apparent only late in the course of disease. 1`3 The presence of autoantibodies is now recognised to be a prominent feature of PSS. Serological abnormalities reported to be characteristic of this disease include precipitating antibodies to the uracyl bases in single-stranded RNA,4 precipitating antibodies to a soluble 70 000 Dalton nuclear protein called Scl-70,6 antinucleolar antibodies,7 and antibodies directed to the centromere region of chromosomes. 8 Recently anticentromere antibody (ACA) has been reported to characterise the CREST variant of PSS.9 10 Such autoantibodies may be of great value if they lead to the earlier diagnosis of PSS or the identification of subsets with differing prognosis.
In the present study we have investigated the frequencies and clinical associations of these and other autoantibodies in the sera of 75 patients with PSS.
Accepted for publication 15 January 1982. Correspondence to P. J. Maddison (29%) as discrete large speckles in interphase nuclei with characteristic clustering during mitosis (Fig. 2) . Precipitating antibodies to extractable antigens. Precipitating antibodies were detected in 40 of the 75 sera (53%). They included anti-Scl-70 in 16 sera (21%) and anti-nRNP, anti-Ro, and anti-PM-Scl-DM"4 in 3 sera each. The remaining 15 precipitins, detected chiefly with calf thymus nuclear extract, were not identical to other known precipitin systems and were heterogeneous among themselves.
Antibodies to ssRNA. Only 4 of 32 sera had antibodies to single-stranded RNA. In contrast to previous reports4 5 these antibodies reacted with doublestranded poly-A-poly-U and failed to react with poly-U.
Clinical associations. ACA=Anticentromere antibodies. 
